These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21093863)

  • 1. The effects of estrogen deficiency and bisphosphonate treatment on tissue mineralisation and stiffness in an ovine model of osteoporosis.
    Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ; McNamara LM
    J Biomech; 2011 Feb; 44(3):386-90. PubMed ID: 21093863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis.
    Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ
    J Orthop Res; 2011 Mar; 29(3):419-24. PubMed ID: 20886644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution.
    Brennan MA; Gleeson JP; O'Brien FJ; McNamara LM
    J Mech Behav Biomed Mater; 2014 Jan; 29():161-70. PubMed ID: 24090875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomechanical properties across trabeculae from the proximal femur of normal and ovariectomised sheep.
    Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ
    J Biomech; 2009 Mar; 42(4):498-503. PubMed ID: 19171344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
    Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid.
    Gamsjaeger S; Buchinger B; Zwettler E; Recker R; Black D; Gasser JA; Eriksen EF; Klaushofer K; Paschalis EP
    J Bone Miner Res; 2011 Jan; 26(1):12-8. PubMed ID: 20645415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
    Little DG; Smith NC; Williams PR; Briody JN; Bilston LE; Smith EJ; Gardiner EM; Cowell CT
    J Bone Miner Res; 2003 Jul; 18(7):1300-7. PubMed ID: 12854841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.
    Simm PJ; Johannesen J; Briody J; McQuade M; Hsu B; Bridge C; Little DG; Cowell CT; Munns CF
    Bone; 2011 Nov; 49(5):939-43. PubMed ID: 21820091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid treatment of ovariectomized sheep affects mineral density, structure, and mechanical properties of cancellous bone.
    Schorlemmer S; Gohl C; Iwabu S; Ignatius A; Claes L; Augat P
    J Bone Miner Res; 2003 Nov; 18(11):2010-5. PubMed ID: 14606514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of zoledronic acid on osseointegration of titanium implants: an experimental study in an ovariectomized rabbit model.
    Yildiz A; Esen E; Kürkçü M; Damlar I; Dağlioğlu K; Akova T
    J Oral Maxillofac Surg; 2010 Mar; 68(3):515-23. PubMed ID: 20171470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
    Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
    Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
    Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
    Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
    Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
    Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model.
    Phillips FM; Turner AS; Seim HB; MacLeay J; Toth CA; Pierce AR; Wheeler DL
    Spine J; 2006; 6(5):500-6. PubMed ID: 16934718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.